New generation probiotics
DOI:
https://doi.org/10.61997/bjm.v8i2.194Keywords:
new generation probiotics, intestinal microbiota, disbiosis, modulationAbstract
The intestinal microbiota plays a decisive role in intestinal homeostasis, and its imbalance is considered a determining factor in the pathogenesis of intestinal and systemic diseases. Likewise, the arguments for the modulation of the microbiota and the foundations for the use of the so-called Next Generation Probiotics are updated. They are an expression of the new knowledge achieved in recent years, with multi-omic methods for diagnosis and therapy of the aforementioned diseases. The promising biotherapeutic strategies proposed with the use of New Generation Probiotics for diseases related to dysbiosis are reviewed.
Downloads
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.





